INDUCTION OF TUMOR SPECIFIC CYTOTOXIC T LYMPHOCYTES IN PROSTATE CANCER USING PROSTATIC ACID PHOSPHATASE DERIVED HLA-A2402 BINDING PEPTIDE
- 1 October 2001
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- p. 1508-1513
- https://doi.org/10.1097/00005392-200110000-00082
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Immunotherapy of Hormone-Refractory Prostate Cancer With Antigen-Loaded Dendritic CellsJournal of Clinical Oncology, 2000
- Identification of a Gene Coding for a New Squamous Cell Carcinoma Antigen Recognized by the CTLThe Journal of Immunology, 2000
- A Cyclophilin B Gene Encodes Antigenic Epitopes Recognized by HLA-A24-Restricted and Tumor-Specific CTLsThe Journal of Immunology, 1999
- Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cellsNature Medicine, 1998
- A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.The Journal of Experimental Medicine, 1996
- Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGES‐3International Journal of Cancer, 1995
- A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3European Journal of Immunology, 1994
- Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.The Journal of Experimental Medicine, 1994
- A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.The Journal of Experimental Medicine, 1992
- Clinical use of tumor markers in oncologyCurrent Problems in Cancer, 1991